Allergenis
About this raise
Allergenis, with a valuation of $40 million, is raising funds on StartEngine. The company uses cutting-edge systems biology and data analytics to provide next-generation food allergy testing. The Allergenis system of testing determines tolerance levels, allergic status, and reaction severity to provide a better-informed quality of life. Currently, Allergenis provides peanut allergic status and threshold testing in 49 states and Washington, DC, and plans to launch milk allergy testing in 2023 and egg allergy testing in 2024. Jim Garner founded Allergenis in September 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1.24 million. The campaign proceeds will be used for sales and marketing, clinical operations, research and development, and general and administrative expenses.
Investment Overview
Invested $560,602 :
Deal Terms
Company & Team
Company
- Year Founded
- 2017
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B/B2C
- Margin
- High
- Capital Intensity
- Low
Financials
- Revenue -72.5% YoY
-
$74,140
as of FY2022
- Monthly Burn
-
$412,716
as of FY2022
-
Runway
-
0.1 months
as of FY2022
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $19,000,000
- VC Backed?
- No
Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|
08/21/2023 | StartEngine | $40,000,005 | $560,602 | Equity - Common | Funded | RegCF |